Commentary on: "Human umbilical cord wharton's jelly-derived mesenchymal stem cell transplantation could improve diabetic intracavernosal pressure"

Asian J Androl. 2022 Mar-Apr;24(2):226-227. doi: 10.4103/aja.aja_52_21.

Authors

Fotios Dimitriadis¹, Vasileios Palapelas², Athanasios Zachariou³, Ioannis Sokolakis⁴

Affiliations

¹ Department of Urology, Aristotle University, School of Medicine, Thessaloniki, Greece.
² 3rd Department of Obstetrics and Gynecology, Aristotle University, School of Medicine, Thessaloniki, Greece.
³ Department of Urology, Ioannina University, School of Medicine, Ioannina, Greece.
⁴ Department of Urology, Martha-Maria Hospital Nuremberg, Nuremberg, Germany.

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus*
Humans
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Umbilical Cord
Wharton Jelly*